Genomic Valley Biotech Limited reported earnings results for the fourth quarter and full year ended March 31, 2024. For the fourth quarter, the company reported net loss was INR 0.445993 million compared to net income of INR 9.8 million a year ago. Basic loss per share from continuing operations was INR 0.15 compared to basic earnings per share from continuing operations of INR 3.21 a year ago. Diluted loss per share from continuing operations was INR 0.15 compared to diluted earnings per share from continuing operations of INR 3.21 a year ago. Basic loss per share was INR 0.15 compared to basic earnings per share of INR 3.21 a year ago. Diluted loss per share was INR 0.15 compared to diluted earnings per share of INR 3.21 a year ago.
For the full year, sales was INR 1.65 million compared to INR 27.23 million a year ago. Revenue was INR 1.67 million compared to INR 27.65 million a year ago. Net income was INR 0.151818 million compared to INR 6.48 million a year ago. Basic earnings per share from continuing operations was INR 0.05 compared to INR 2.12 a year ago. Diluted earnings per share from continuing operations was INR 0.05 compared to INR 2.12 a year ago.